Roivant Sciences (ROIV) News
NASDAQ: ROIVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
35.44+1.23 (+3.60%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ROIV news summary
We found 1 recent headline mentioning Roivant Sciences (ROIV): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ROIV is up 3.60% at $35.44. The most recent story, "New FDA Drug Approvals - August 2026", was published by Nasdaq on Sep 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology